Why must Olympic athletes prove that they have asthma to be permitted to take inhaled β2-agonists?

被引：9

作者：

Weiler, JM ^{[1
]}

机构：

[1] Univ Iowa, Iowa City, IA 52242 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2003年 / 111卷 / 01期

关键词：

D O I：

10.1067/mai.2003.113

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：36 / 37

页数：2

共 50 条

[31] Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
Joseph Emil Amegadzie
John-Michael Gamble
Jamie Farrell
Zhiwei Gao
Respiratory Research, 23
[32] Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
Amegadzie, Joseph Emil
Gamble, John-Michael
Farrell, Jamie
Gao, Zhiwei
RESPIRATORY RESEARCH, 2022, 23 (01)
[33] Comparison of the bronchodilator effect of inhaled short- and long-acting β2-agonists in children with bronchial asthma a randomised trial
Verini, M
Verrotti, A
Greco, R
Chiarelli, F
CLINICAL DRUG INVESTIGATION, 1998, 16 (01) : 19 - 24
[34] Long-Acting β2-Agonists or Leukotriene Receptor Antagonists as Add-On Therapy to Inhaled Corticosteroids for the Treatment of Persistent Asthma
Nils Ringdal
Drugs, 2003, 63 (Suppl 2) : 21 - 33
[35] Asthma control in adult patients treated with a combination of inhaled corticosteroids and long-acting β2-agonists: a prospective observational study
Rogala, Barbara
Majak, Pawel
Gluck, Joanna
Debowski, Tomasz
POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (02): : 100 - 106
[36] Asthma control achieved with inhaled corticosteroids and long-acting β2-agonists in a free or fixed combination -: Results of the ALISE survey
Serrier, P
Roche, N
Pello, JY
Larguier, JS
Mezzi, K
PRESSE MEDICALE, 2003, 32 (11): : 493 - 497
[37] Do Inhaled B2-Agonists have an Ergogenic Potential in Non-Asthmatic Competitive Athletes?
Wilfried Kindermann
Sports Medicine, 2007, 37 : 95 - 102
[38] Combination inhalers containing inhaled corticosteroids and long-acting β2-agonists:: Improved clinical efficacy and dosing options in patients with asthma
Ankerst, J
JOURNAL OF ASTHMA, 2005, 42 (09) : 715 - 724
[39] Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization
Hanania, Nicola A.
Settipane, Russell A.
Khoury, Samir
Shaikh, Asif
Dotiwala, Zenobia
Casciano, Julian
Foggs, Michael B.
ALLERGY AND ASTHMA PROCEEDINGS, 2023, 44 (06) : 413 - 421
[40] Effects of Inhaled Corticosteroids, Leukotriene Receptor Antagonists, or Both, Plus Long-Acting β2-Agonists on Asthma Pathophysiology: a Review of the Evidence
A. Maurizio Vignola
Drugs, 2003, 63 (Suppl 2) : 35 - 51

← 1 2 3 4 5 →